LoginSign Up
Zymergen

Zymergen

Zymergen, founded in 2013 and located in Emeryville, California, is a technology company providing organisms engineering services. Their biotechnology labs rely on advanced manufacturing technologies, machine learning techniques, and genomics to accelerate the design, build, test cycle of microorganisms.

Zymergen, founded in 2013 and located in Emeryville, California, is a technology company providing organisms engineering services. Their biotechnology labs rely on advanced manufacturing technologies, machine learning techniques, and genomics to accelerate the design, build, test cycle of microorganisms. Zymergen claims they have the world's largest database of proprietary physical and digital DNA library in the world. The company provides their services to industrial biotechnology customers seeking to improve the cost efficiency of existing strains, or engineer new strains, that manufacture chemicals, food or food additives, and materials using microorganisms.

Partnership, mergers and acquisitions

Radiant Genomics

On January 8, 2018 Zymergen acquired a functional metagenomics research company named Radiant Genomics. With this acquisition Zymergens gets to add the metagenomic technologies and genetic libraries developed by Radiant Genomics to its core platform. Zymergen hopes acquiring Radiant Genomics will help accelerate its ability to identify and create useful organisms and molecules. The CEO of Zymergen had the following to say about the acquisition: "Radiant has built an unparalleled platform and set of libraries to search genetic diversity that will allow us to search for these molecules of interest, extending our ability to produce useful molecules for materials that can transform the world around us."

Funding

Seed round

On January 1, 2014 Zymergen raised $2,000,000 in seed funding from Genoa Ventures (lead investor), Linden Mobile Ventures, Josh Perfetto, Jesse Robbins, Jenny Rooke, and David Beyer.

Series A

On June 16, 2015 Zymergen completed their Series A funding round raising $42,000,000 in funding from Data Collective (lead investor), AME Cloud Ventures, DFJ, Genoa Ventures, Two Sigma Ventures, True Ventures, SciFI VC, Obvious Ventures, Innovation Endeavors, and Jenny Rooke.

Series B

On October 11, 2016 Zymergen completed their Series B funding round raising $130,000,000 in funding from Soft Bank (lead investor), Two Sigma, Tao Capital Partners, Prelude Ventures, Obvious Ventures, Innovation Endeavors, ICONIQ Capital, Data Collective, DFJ, and AME Cloud Ventures.

Timeline

Zymergen acquires Radiant Genomics

On January 8, 2018 Zymergen acquired a functional metagenomics research company named Radiant Genomics. With this acquisition Zymergens gets to add the metagenomic technologies and genetic libraries developed by Radiant Genomics to it's core platform. Zymergen hopes acquiring Radiant Genomics will help accelerate it's ability to identify and create useful organisms and molecules. The CEO of Zymergen had the following to say about the acquisition of radiant genomics "Radiant has built an unparalleled platform and set of libraries to search genetic diversity that will allow us to search for these molecules of interest, extending our ability to produce useful molecules for materials that can transform the world around us."

Zymergen completes $130 million dollar Series B funding round.

On October 11, 2016 Zymergen completed their Series B funding round raising $130,000,000 in funding from Soft Bank (lead investor), Two Sigma, Tao Capital Partners, Prelude Ventures, Obvious Ventures, Innovation Endeavors, ICONIQ Capital, Data Collective, DFJ, and AME Cloud Ventures.

Zymergen completes $42 million dollar Series A funding round.

On June 16, 2015 Zymergen completed their Series A funding round raising $42,000,000 in funding from Data Collective (lead investor), AME Cloud Ventures, DFJ, Genoa Ventures, Two Sigma Ventures, True Ventures, SciFI VC, Obvious Ventures, Innovation Endeavors, and Jenny Rooke.

Zymergen completes $2 million dollar seed funding round .

On January 1, 2014 Zymergen raised $2,000,000 in seed funding from Genoa Ventures (lead investor), Linden Mobile Ventures, Josh Perfetto, Jesse Robbins, Jenny Rooke, and David Beyer.

Founding of Zymergen

Zymergen, founded in 2013 and located in Emeryville, California, is a technology company providing organisms engineering services.

People

Name
Role
Related Golden topics

David St Clair

Advisor

Jed Dean

VP of Operations and Engineering, Co-founder

Chief Executive Officer, Co-founder

Paul Jansen

Board member

Vonnie Estes

Board member

Chief Science Officer, VP of Development, Co-founder

Further reading

Author
Title
Link
Type

Business Wire

Zymergen Acquires Metagenomics Company Radiant Genomics

News article

Clare McGrane

Bay-Area biotech startup Zymergen opens Seattle office, signaling big growth plans in the city

News article

Mark Terry

What You Need to Know About Zymergen | BioSpace

Web article

Michael J. de la Merced

SoftBank Wants to Build the Future. Here Are Some New Bets It Could Make.

News article

Documentaries, videos and podcasts

Title
Date
Link

Designing a Million Genomes: Machine Learning, Automation and Biotech

October 7, 2015

Joshua Hoffman - CEO, Zymergen | Near Future Summit

November 15, 2016

KPMGVoice: Zymergen - The Great Rewrite | Forbes

May 4, 2017

Zymergen: Unlocking the Power of Biology through Technology - Zach Serber at impact.tech at GoogleSF

August 13, 2016

Companies

Company
CEO
Location
Products/Services

References